Glucomannan Related Medical Research Constipation Cholesterol Diabetes Obesity Colonic pathology
Diabetes Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. {pdf format} Long-term effects of dietary fiber supplementation on serum glucose and lipoprotein levels in diabetic rats fed a high cholesterol diet. Dietary fiber in the dietetic therapy of diabetes mellitus. Experimental data with purified glucomannans Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial. {pdf format} Effect of Konjac food on blood glucose level in patients with diabetes. Effects of long-term high-fiber diet on macrovascular changes and lipid and glucose levels in STZ-induced diabetic SD rats.
Cholesterol Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed "Western" diets. Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption. Antisteatotic effects of four kinds of dietary fibers in rats fed on high cholesterol diet: a preliminary morphometric analysis Effects of dietary konjac mannan on serum and liver cholesterol levels and biliary bile acid composition in hamsters. Influences of refined konjac meal on the levels of tissue lipids and the absorption of four minerals in rats.
Obesity Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo. The use of highly purified glucomannan-based fibers in childhood obesity Chronic use of glucomannan in the dietary treatment of severe obesity Effect of glucomannan on obese patients: a clinical study. Constipation Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children. A clinical study of the use of a combination of glucomannan with lactulose in the constipation of pregnancy Action of glucomannans on complaints in patients affected with chronic constipation: a multicentric clinical evaluation. Mouth-to-cecum transit time in patients affected by chronic constipation: effect of glucomannan. Colonic pathology Purification and characterization of konjac glucomannan degrading enzyme from anaerobic human intestinal bacterium, Clostridium butyricum-Clostridium beijerinckii group. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Use of glucomannan dietary fiber in changes in intestinal habit Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Others Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery. Dietary fiber and OGTT: blood sugar variations after administration of a new purified glucomannane Long-term animal feeding trial of the refined konjac meal. II. Effects of the refined konjac meal on the aging of the brain, liver, and cardiovascular tissue cells in rats. Inhibitory effect of refined Amorphophallus konjac on MNNG-induced lung cancers in mice Immunologic clinical evaluation of a biological response modifier, AM3, in the treatment of childhood infectious respiratory pathology